Minimally Invasive Device Repair of Ascending Aortic Pathology in Selected High-risk Patients
Debin Liu,Hong Wang,Yongnan Li,Qi Ma,Weifang Wang,Xiaofeng Wang,Jinlin Su
DOI: https://doi.org/10.1097/sla.0000000000005333
IF: 13.787
2022-01-01
Annals of Surgery
Abstract:Intimai tear in ascending aorta usually develops following aortic pathology, such as aortic dissection and aortic pseudoaneurysm after thoracic surgery.1–4 Open aortic replacement is the conventionally gold standard for ascending aortic pathology. In this report, we describe our initial experience with a novel minimally invasive device repair (MIDR) for intimal tear in ascending aorta in high-risk patients under transesophageal echocardiographic (TEE) guidance. METHODS Patient's Clinical Details Between January 2017 and January 2021, 10 selected patients with intimal tear in ascending aorta were selected for MIDR. Clinical data was summarized in Table 1. The clinical protocol was approved by the Ethics Committee of the hospital and all patients provided informed written consent. TABLE 1 - Clinical Characteristic Data and Treatment Results Pt. No. Characteristic 1 2 3 4 5 6 7 8 9 10 Age (yr)/sex 71/F 69/M 68/F 67/M 69/M 53/F 74/M 67/F 58/M 72/M Clinical symptoms and signs Sudden chest pain Yes No Yes Yes No No Yes No Yes No Coronary artery disease Yes No Yes No Yes Yes Yes No Yes Yes Previous revascularization — — PCI — CABG PCI CABG — PCI PCI Previous cardiac surgery — Bentall — — AVR Bentall AVR Bentall — — Other complications Hypertension — Mild Mod Mild — Mod Mod Mod Mild Mod Moderate to severe COPD Yes — Yes — Yes Yes — — Yes — Renal insufficiency None Mod Mild Mod None Mild Mod Mild Mod Mild Diabetes mellitus Yes — — Yes — — Yes — Yes Yes LVEF (%) 45 48 52 56 51 40 58 47 45 49 HF (NYHA) III II III III III IV II III III II Log EuroSCORE II 11.5 13.7 9.6 17.9 21.5 15.1 12.6 12.8 11.5 12.5 Indication for MIDR TII-AD AAPA TII-AD PAU TII-AD AAPA TI-AD PAU TII-AD TII-AD Perioperative data Intimal tear at ascending aorta RAL RAL AW LAL AW RAL AW AW AW RAL Diameter of intimal tear (mm) 8 5 7 18 22 5 10 15 10 8 Diameter of ascending aorta (mm) 55 67 58 45 67 56 65 42 45 51 Surgical access RAMT PUMS RAMT PUMS RAMT RAMT PUMS PUMS PUMS RAMT Device type VSD VSD VSD ASD ASD VSD VSD ASD VSD VSD Device Size (mm) 10 6 8 + 8 20 26 6 10 16 12 10 IAMT (min) 38 35 33 31 27 42 39 23 35 36 Hospital stay (d) 8 6 9 11 7 8 8 10 12 9 Follow up (m) 18 26 22 36 45 19 27 10 6 12 Complications — — — — — — — — — — AAPA indicates ascending aortic pseudoaneurysm; ASD, atrial septal defect; AVR, aortic valve replacement; AW, anterior wall of aorta; CABG, coronary artery bypass grafting; COPD, chronic obstructive pulmonary disease; HF, heart failure; IAMT, intra-aortic manipulation time; LAL, left anterolateral; LVEF, left ventricular ejection fraction; MIDR, minimally invasive device repair; Mod, moderate; NYHA, New York Heart Association; PAU, penetrating atherosclerotic ulcer; PCI, percutaneous coronary intervention; Pt. no., patient number; PUMS, partial upper ministernotomy; RAL, right anterolateral; RAMT, right anterolateral minithoracotomy; TI-AD, DeBakey type I aortic dissection; TII-AD, DeBakey type II aortic dissection; VSD, ventricular septal defect. Inclusion Criteria Each patient had met the following criteria for MIDR: (1) isolated intimal tear in ascending aorta confirmed by transthoracic echocardiographic and computed tomography angiography (CTA); (2) one was deemed a high-risk candidate for open aortic replacement; (3) a sufficient rim of tissue must exist around the intimal tear to allow anchoring of the occluder; (4) duration from onset to MIDR was more than 2 to 4 weeks. patients with both proximal entry tear and distal outflow tear, wave-swing intimal tear, and infective endocarditis were excluded from this series. Procedure With the patient under general anesthesia, a Philips IE33 TEE was used. Two minimally invasive incision, including the right anterior minithoracotomy and partial upper ministernotomy, had been developed in our institution for MIDR. In the patients of right anterior minithoracotomy, a 4-cm right lateral minithoracotomy incision was performed in the third intercostal space. In the patients of partial upper ministernotomy, a 5-cm skin incision was performed midline over the upper segment of sternum. The sternum was split with an oscillating saw from the sternal notch to the third intercostal space as an “L” or “J” incision. When the ascending aorta was exposed, a puncture site on the adventitial of aorta was chosen according to preoperative CTA. Two concentric purse-string sutures of 4–0 polypropylene was placed on the adventitial of puncture site. Unfractionated heparin was administered to achieve an activated clotting time greater than 250 seconds. After puncturing into the aorta, a sheath catheter was advanced into the false lumen (FL) along a J-tip hydrophilic guide wire. Under TEE, the tip of the sheath was adjusted to point to the intimal tear, and the wire was introduced across the leak into the true lumen (TL), then the sheath was followed into TL along the wire. Through the sheath, the occluder (Lifetech Scientific Co. Ltd, Shenzhen, China) was placed and deployed across the defect. It is first disc was opened in TL, and the sheath and device were then withdrawn en bloc until the open first disc was sitting on the TL side of the entry. The second disc of the device was then released in FL. Device position and stability were gently checked by a repeat push-pull maneuver before occluder released. The real-time TEE was performed to navigate the device delivery, to orientate the device location, to evaluate the residual leak around the device. The occluders were released while keeping the secure suture connected with the device for 10 minutes to observe the device position. The puncture point of the adventitial of aorta was closed with purse-string sutures. And the secure suture on the device was also tied. RESULTS The detailed data of treatment, immediate outcomes, and follow-up are summarized in Table 1. The procedures were successful in all patients. Representative case 3 is presented in Figure 1, who was a 68-year-old woman with a chief complaint of chest and back pain, emergent CTA revealed DeBakey type II aortic dissection and presence of an intimal tear at the middle of anterolateral ascending aorta, with a well-defined neck measuring 8 mm (Fig. 1A and B). She underwent successful closure of the intimal tear using two 8-mm mVSD occluders with TEE guidance. Follow-up CTA at 1 year confirmed continued exclusion and remodeling of the aorta (Fig. 1C and D).FIGURE 1: Pre- and postoperative reconstructed computed tomography images of the patient (case 3). A, Axial image from computed tomography angiography (CTA) showing flow into the false lumen through an intimal tear (arrow). B, CTA with 3-dimensional reconstructions revealing an intimal tear at the middle ascending aorta (arrow). C, Axial image of CTA obtained 12 mo later showing successful closure of the intimal tear using mVSD occluders, the resolution of the false lumen and remodeling of the ascending aorta. D, 3D reconstructions of CTA demonstrating satisfactory location of the two 8-mm mVSD occluders 12 mo later.All patients recovered uneventfully and were discharged at 7.8 ± 2.5 days after MIDR and followed for a median period of 21.9 ± 17.6 months. At the time of last follow-up, all patients were alive, and there was no residual endoleak, device embolization, migration or any other complication. DISCUSSION Intimal tear in ascending aortic pathology is an uncommon and catastrophic event, and open aortic replacement with cardio-pulmonary bypass is the gold standard. Nevertheless, patients have increasingly become elderly with multiple medical comorbidities, and recent interest has shifted toward less invasive methods of therapy, such as coil embolization and transcatheter interventions using occluder or stent grafts in high-risk patients.1–8 The benefits of percutaneous transcatheter closure include its relative ease of use, avoidance of general anesthesia, lower surgical morbidity, and mortality. However, some challenging issues remain for each of these approaches. Coils might have a risk for migration and distal embolism.4 Endovascular stent grafting for the ascending aorta is challenged by more complex pathology and hemodynamic characteristics.5 Percutaneous device closure may not be an option in some cases with broad intimal tear, or the device may slip out of the entry tear, or the deployment of device is too difficult to lead to mal-deployment with disastrous outcome.4 To overcome the technical challenges and to avoid the morbidity of complication above mentioned, we designed a novel “hybrid technique” for the device closure of intimal tear in ascending aorta in high-risk patients. The procedures were successful in all 10 selected patients with no endoleak. To the best of our knowledge, our institution is the first to describe the combination of minimally invasive approach and device occlusion of intimal tear in ascending aorta in high-risk patients. Advantages of MIDR for Isolated Intimal Tear in Ascending Aorta (1) From the minimally invasive incision, we were able to practicably cross the intimal tear under TEE guidance, and short operative path gave better control during device delivery, positioning, and deployment. (2) The hybrid procedures did not require X-ray fluoroscopy. (3) The occluder positioning and deployment is to obtain an optimal coaxiality of the delivery sheath and the long axis of the intimal tear. In addition, the operators need to enhance interactive communication with echocardiologist in all procedures. The puncture site at ascending aorta should be carefully preplanned using the echo, because the location of the puncture site is crucial for successful access to the intimal tear. The aortic disc of the device must be seated on the intimal tear without part of the disc slipping into FL. Otherwise, device mal-deployment or residual leak may lead to disastrous outcome. CONCLUSION MIDR for intimal tear in ascending aortic pathology is an effective and promising alternative to other approaches for selected high-risk patients. Larger studies, ideally with a randomized controlled design, are therefore needed to precisely evaluate the superiority of this technique compared with other endovascular approaches.